{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:49:12Z","timestamp":1794584952254,"version":"4.9.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFE0108200"],"award-info":[{"award-number":["2019YFE0108200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan International Science and Technology Cooperation","award":["2022YFH0023"],"award-info":[{"award-number":["2022YFH0023"]}]},{"name":"Science Popularization Base Project of Chengdu Science and Technology Bureau","award":["2022-GH03-00003-HZ"],"award-info":[{"award-number":["2022-GH03-00003-HZ"]}]},{"name":"West China Hospital 1.3.5 Project for Disciplines of Excellence","award":["21HXFH002"],"award-info":[{"award-number":["21HXFH002"]}]},{"name":"West China Hospital Hospital-Enterprise Cooperation Clinical Research Innovation","award":["21HXCX04"],"award-info":[{"award-number":["21HXCX04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Anti-peptidyl arginine deaminase 4 (anti-PAD4) antibody has been a subject of investigation in RA in the last two decades. This meta-analysis investigated the diagnostic values, association with disease activity and possible risk factors of anti-PAD4 antibody in rheumatoid arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We searched studies from five databases up to 1 December 2022. Bivariate mixed-effect models were used to pool the diagnostic accuracy indexes, and the summary receiver operating characteristics (SROC) curve was plotted. The quality of diagnostic studies was assessed using QUADAS-2. Non-diagnostic meta-analyses were conducted using the random-effects model. Sensitivity analysis, meta-regression, subgroup analyses and Deeks\u2019 funnel plot asymmetry test were used to address heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Finally, 24 journal articles and one letter were included. Anti-PAD4 antibody had a good diagnostic value between RA and healthy individuals, but it might be lower between RA and other rheumatic diseases. Moreover, anti-PAD4 could slightly enhance RA diagnostic sensitivity with a combination of ACPA or ACPA\/RF. Anti-PAD4 antibody was positively correlated with HLA-SE and negatively correlated with ever or current smoking in patients with RA. RA patients with anti-PAD4 antibody had higher DAS28, ESR, swollen joint count (SJC) and the possibility of having interstitial lung disease (ILD) and pulmonary fibrosis compared with those without.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study suggests that anti-PAD4 antibody is a potentially useful diagnostic biomarker and clinical indicator for RA. Further mechanistic studies are required to understand the impact of HLA-SE and smoking on the production of anti-PAD4 antibody.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead545","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T23:35:24Z","timestamp":1697067324000},"page":"914-924","source":"Crossref","is-referenced-by-count":14,"title":["Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis"],"prefix":"10.1093","volume":"63","author":[{"given":"Guangyue","family":"Zhang","sequence":"first","affiliation":[{"name":"West China School of Medicine, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[{"name":"West China School of Medicine, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongru","family":"Du","sequence":"additional","affiliation":[{"name":"West China School of Medicine, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunzhi","family":"Dai","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-8906","authenticated-orcid":false,"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University , Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"2024040216352209900_kead545-B1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"2024040216352209900_kead545-B3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BOR.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2024040216352209900_kead545-B4","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"van de Stadt","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2024040216352209900_kead545-B5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imr.12834","article-title":"Insights into the study and origin of the citrullinome in rheumatoid arthritis","volume":"294","author":"Fert-Bober","year":"2020","journal-title":"Immunol Rev"},{"key":"2024040216352209900_kead545-B6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/07853890.2014.907097","article-title":"HLA and rheumatoid arthritis: how do they connect?","volume":"46","author":"van Heemst","year":"2014","journal-title":"Ann Med"},{"key":"2024040216352209900_kead545-B7","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/art.39215","article-title":"The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis","volume":"67","author":"Chang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2024040216352209900_kead545-B8","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.3390\/cimb44090293","article-title":"PADI4 haplotypes contribute to mRNA expression, the enzymatic activity of peptidyl arginine deaminase and rheumatoid arthritis risk in patients from western Mexico","volume":"44","author":"Matuz-Flores","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"2024040216352209900_kead545-B9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-220546","article-title":"Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis","volume":"81","author":"Wouters","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B10","doi-asserted-by":"crossref","first-page":"956417","DOI":"10.3389\/fcimb.2022.956417","article-title":"The relationship between porphyromonas gingivalis and rheumatoid arthritis: a meta-analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2024040216352209900_kead545-B11","doi-asserted-by":"crossref","first-page":"804822","DOI":"10.3389\/fimmu.2022.804822","article-title":"Antibodies to a citrullinated porphyromonas gingivalis epitope are increased in early rheumatoid arthritis, and can be produced by gingival tissue B cells: implications for a bacterial origin in RA etiology","volume":"13","author":"Sherina","year":"2022","journal-title":"Front Immunol"},{"key":"2024040216352209900_kead545-B12","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2024040216352209900_kead545-B13","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3389\/fimmu.2018.02696","article-title":"Autoantibodies to peptidylarginine deiminase 2 are associated with less severe disease in rheumatoid arthritis","volume":"9","author":"Darrah","year":"2018","journal-title":"Front Immunol"},{"key":"2024040216352209900_kead545-B14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/03009740510026346-1","article-title":"Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis","volume":"34","author":"Takizawa","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"2024040216352209900_kead545-B15","doi-asserted-by":"crossref","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"key":"2024040216352209900_kead545-B16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","article-title":"Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans","volume":"18","author":"Navarro-Millan","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2024040216352209900_kead545-B17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2008.094490","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents","volume":"68","author":"Halvorsen","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/art.40791","article-title":"Association of baseline peptidylarginine deiminase 4 autoantibodies with favorable response to treatment escalation in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024040216352209900_kead545-B19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00296-010-1765-y","article-title":"Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate","volume":"32","author":"Pollmann","year":"2012","journal-title":"Rheumatol Int"},{"key":"2024040216352209900_kead545-B20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/art.27230","article-title":"Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen","volume":"62","author":"Auger","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024040216352209900_kead545-B21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/1744666X.2020.1668778","article-title":"Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine","volume":"15","author":"Martinez-Prat","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2024040216352209900_kead545-B22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.autrev.2017.11.023","article-title":"Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis","volume":"17","author":"Reyes-Castillo","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2024040216352209900_kead545-B23","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s10067-017-3809-0","article-title":"Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis","volume":"36","author":"Ren","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2024040216352209900_kead545-B24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2024040216352209900_kead545-B25","first-page":"969","article-title":"Prevalence and Significance of Anti-Peptidylarginine Deiminase 4 Antibodies in Rheumatoid Arthritis","volume":"35","author":"Jinxia","year":"2008","journal-title":"J Rheumatol"},{"key":"2024040216352209900_kead545-B26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-010-1671-4","article-title":"Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis","volume":"30","author":"Wang","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2024040216352209900_kead545-B27","first-page":"229","article-title":"The association between anti-peptidylarginine deiminase IV antibodies and rheumatoid arthritis","volume":"34","author":"Xiuming","year":"2012","journal-title":"J Ningxia Med Univ"},{"key":"2024040216352209900_kead545-B28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/s10165-012-0748-0","article-title":"Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis","volume":"23","author":"Ishigami","year":"2013","journal-title":"Mod Rheumatol"},{"key":"2024040216352209900_kead545-B29","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10067-015-3082-z","article-title":"Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases","volume":"35","author":"Umeda","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2024040216352209900_kead545-B30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.12677","article-title":"Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features","volume":"182","author":"Reyes-Castillo","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2024040216352209900_kead545-B31","first-page":"59","article-title":"Study of Peptidyl Arginine Deiminases 4 (PAD 4) antibodies in rheumatoid arthritis patients","volume":"4","author":"El-Hallous","year":"2016","journal-title":"Egyptian J Rheumatol Clin Immunol"},{"key":"2024040216352209900_kead545-B32","first-page":"49","article-title":"Combinations of autoantibodies and their association with clinical variables in rheumatoid arthritis","volume":"52","author":"Hern\u00e1ndez-Bello","year":"2018","journal-title":"Acta Bioquim Clin Latinoam"},{"key":"2024040216352209900_kead545-B33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/annrheumdis-2018-213818","article-title":"Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis","volume":"78","author":"Martinez-Prat","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B34","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s10067-019-04681-4","article-title":"Cytokines (IL-15, IL-21, and IFN-gamma) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity","volume":"38","author":"Reyes-Perez","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2024040216352209900_kead545-B35","first-page":"1291","article-title":"Diagnostic value of anti-CarP antibody and anti-PAD4 antibody for rheumatoid arthritis","volume":"40","author":"Hongmei","year":"2019","journal-title":"Guangdong Yi Xue"},{"key":"2024040216352209900_kead545-B36","first-page":"1035","article-title":"Clinical relevance of autoantibodies targeting peptidylarginine deiminases 2 and 4 in rheumatoid arthritis","volume":"44","author":"Zhan","year":"2021","journal-title":"Chin J Lab Med"},{"key":"2024040216352209900_kead545-B37","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1038\/s41598-022-15726-1","article-title":"The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis","volume":"12","author":"Ciesla","year":"2022","journal-title":"Sci Rep"},{"key":"2024040216352209900_kead545-B38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2007.080267","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity","volume":"67","author":"Halvorsen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B39","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2024040216352209900_kead545-B40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"2024040216352209900_kead545-B41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.semarthrit.2014.09.006","article-title":"Does non-erosive rheumatoid arthritis exist? A cross-sectional analysis and a systematic literature review","volume":"44","author":"Amaya-Amaya","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2024040216352209900_kead545-B42","doi-asserted-by":"crossref","first-page":"A19.2","DOI":"10.1136\/annrheumdis-2016-209124.46","article-title":"Antibodies to carbamylated \u03b1-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anticitrullinated protein antibodies","volume":"75","author":"Reed","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/antib8020037","article-title":"Specificity of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"8","author":"Trier","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"2024040216352209900_kead545-B44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/antib11010020","article-title":"Reactivity of rheumatoid arthritis-associated citrulline-dependent antibodies to Epstein-Barr virus nuclear antigen1-3","volume":"11","author":"Fanelli","year":"2022","journal-title":"Antibodies (Basel)"},{"key":"2024040216352209900_kead545-B45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-018-1533-z","article-title":"Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis","volume":"20","author":"Cappelli","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2024040216352209900_kead545-B46","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3899\/jrheum.170769","article-title":"Lack of association among peptidyl arginine deiminase type 4 autoantibodies, PADI4 polymorphisms, and clinical characteristics in rheumatoid arthritis","volume":"45","author":"Guderud","year":"2018","journal-title":"J Rheumatol"},{"key":"2024040216352209900_kead545-B47","doi-asserted-by":"crossref","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease","volume":"9","author":"Giles","year":"2014","journal-title":"PLoS One"},{"key":"2024040216352209900_kead545-B48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3899\/jrheum.130293","article-title":"Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations","volume":"40","author":"Ferucci","year":"2013","journal-title":"J Rheumatol"},{"key":"2024040216352209900_kead545-B49","doi-asserted-by":"crossref","first-page":"1759720X21989868","DOI":"10.1177\/1759720X21989868","article-title":"The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA\/RF negative rheumatoid arthritis patients","volume":"13","author":"Kolarz","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2024040216352209900_kead545-B50","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar4255","article-title":"New autoantibodies in early rheumatoid arthritis","volume":"15","author":"Charpin","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2024040216352209900_kead545-B51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.gpb.2018.11.004","article-title":"Novel autoantibodies related to cell death and DNA repair pathways in systemic lupus erythematosus","volume":"17","author":"Luo","year":"2019","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2024040216352209900_kead545-B52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/03009742.2018.1469164","article-title":"Anti-citrullinated protein antibodies and arthritis in Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"48","author":"Molano-Gonz\u00e1lez","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2024040216352209900_kead545-B53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0961203309102817","article-title":"The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus","volume":"18","author":"Qing","year":"2009","journal-title":"Lupus"},{"key":"2024040216352209900_kead545-B54","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/annrheumdis-2016-209991","article-title":"Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands","volume":"76","author":"van Zanten","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B55","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/annrheumdis-2019-215434","article-title":"Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus","volume":"78","author":"Odqvist","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024040216352209900_kead545-B56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-022-02860-4","article-title":"The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjogren's syndrome","volume":"24","author":"Peng","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2024040216352209900_kead545-B57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2024040216352209900_kead545-B58","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/diagnostics12092187","article-title":"Anti-protein-arginine deiminase 4 IgG and IgA delineate severe rheumatoid arthritis","volume":"12","author":"Martinez-Prat","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2024040216352209900_kead545-B59","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.jaut.2020.102542","article-title":"Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?","volume":"116","author":"Balandraud","year":"2021","journal-title":"J Autoimmun"},{"key":"2024040216352209900_kead545-B60","doi-asserted-by":"crossref","first-page":"840035","DOI":"10.3389\/fimmu.2022.840035","article-title":"PAD4 immunization triggers anti-citrullinated peptide antibodies in normal mice: analysis with peptide arrays","volume":"13","author":"Hemon","year":"2022","journal-title":"Front Immunol"},{"key":"2024040216352209900_kead545-B61","doi-asserted-by":"crossref","first-page":"E10169","DOI":"10.1073\/pnas.1713112114","article-title":"Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types","volume":"114","author":"Arnoux","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024040216352209900_kead545-B62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/acs.jproteome.6b00617","article-title":"Proteolysis by granzyme B enhances presentation of autoantigenic peptidylarginine deiminase 4 epitopes in rheumatoid arthritis","volume":"16","author":"Darrah","year":"2017","journal-title":"J Proteome Res"},{"key":"2024040216352209900_kead545-B63","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/art.42262","article-title":"Heavy chain constant region usage in antibodies to peptidylarginine deiminase 4 as a marker of disease subsets in rheumatoid arthritis","volume":"74","author":"G\u00f3mez-Ba\u00f1uelos","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2024040216352209900_kead545-B64","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/rheumatology\/keac667","article-title":"Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis","volume":"62","author":"Palterer","year":"2023","journal-title":"Rheumatology (Oxford"},{"key":"2024040216352209900_kead545-B65","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1093\/rheumatology\/keab050","article-title":"Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis","volume":"60","author":"Lamacchia","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216352209900_kead545-B66","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjms.2023.03.003","article-title":"Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival","volume":"365","author":"Wilson","year":"2023","journal-title":"Am J Med Sci"},{"key":"2024040216352209900_kead545-B67","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jcf.2018.12.010","article-title":"Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis","volume":"18","author":"Yadav","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024040216352209900_kead545-B68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/08916934.2021.2021193","article-title":"Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity","volume":"55","author":"Linnemann","year":"2022","journal-title":"Autoimmunity"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead545\/52547817\/kead545.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/914\/57140484\/kead545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/914\/57140484\/kead545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T14:25:03Z","timestamp":1712067903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/4\/914\/7308771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10,12]]},"published-print":{"date-parts":[[2024,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead545","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,10,12]]}}}